Latest Johnson & Johnson Stories
NEW BRUNSWICK, N.J., March 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will webcast its Annual Meeting of Shareholders at 10 a.m.
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 LONDON, March 26, 2015 /PRNewswire/ -- SummaryRheumatoid arthritis (RA) is a chronic
1-DAY ACUVUE® DEFINE(TM) Brand Contact Lenses Create a New Category of Eye Enhancement Contact Lenses JACKSONVILLE, Fla., March 26, 2015 /PRNewswire/ -- Johnson & Johnson Vision Care,
Case lists issued on March 21st indicates that 169 new vaginal mesh lawsuits have been filed over the past month in New Jersey’s Bergen County Superior Court, all of which allege pelvic mesh
Case Funding Firm reports that a transvaginal mesh settlement was reached by J&J's Ethicon subsidiary just one day after the recent $5.7 million verdict was reached against them in a different trial.
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
Settlement of the Bellwether Case Maintains Efficiency of Legal Process & Meets Request of Federal Judge, Say Carey Danis & Lowe Attorneys St.
Investigational Anti-thrombin Antibody Ichorcumab Strengthens Cardiovascular Disease Portfolio RARITAN, N.J., March 19, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc.
NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m.
With Nearly 120,000 Votes in 24 Categories, BabyCenter Parents Select Their Favorite Products SAN FRANCISCO, March 17, 2015 /PRNewswire/ --
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).